Member Directory

FB Rice


Member Contact: Jenny Petering

Position: Of Counsel

Industry: Industry Support Services

Company Profile:

The FB Rice Biotechnology Group specialises in intellectual property matters relating to the biological sciences, including the provision of advice on patentability and infringement, drafting and prosecution of patent applications and portfolio management.
We are experts in the protection of intellectual property and we work with our clients to create strategies with high commercial impact. Our clients trust us to examine their organisation’s strategy and vision, as well as to help realise it.

From Australian and international corporations, Co-operative Research Centres, universities, research institutes and start-up companies, we’re helping our clients “put good ideas to work”. FB Rice also provides comprehensive due diligence advice including conducting and reporting on patent searches. We have extensive experience in protecting inventions in animal, plant and microbial systems, particularly those involving genetic engineering, functional genomics, proteomics, stem cell technology, diagnostics and drug screening assays. We also advise on Plant Breeder’s Rights for new plant varieties, and attend to the preparation, filing and prosecution of PBR applications.

Founded over sixty years ago, FB Rice is Australia’s leading independent intellectual property firm. We do not have a law firm within our practice, nor are we aligned to any one law firm. So intellectual property is our sole focus, which ensures the best possible development and protection for our clients' intellectual property. Clients also value our ability to understand both the technology they deal with, as well as the commercial imperatives under which they operate.

FB Rice has also been nominated as a finalist in the 2016 Financial Review Client Awards and is a finalist in the Managing IP Global Awards. A recent edition of the annual survey of IP firms ‘Managing IP’ noted that: ‘The firm maintains a reputation for excellence in the biotechnology, medical technology and IT spaces’.


News & opinion

Member Directory